ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal ant...
Leadership
Kristin Yarema Ph.D.
CEO, Director & Interim Principal Financial Officer
Robert Lally
Senior VP of Finance & Operations and Principal Accounting Officer
